XML 97 R84.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events (Details Narrative) (10-K) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Apr. 10, 2018
Jan. 04, 2018
May 31, 2017
Mar. 30, 2018
Sep. 30, 2018
Dec. 31, 2017
Dec. 31, 2016
Series A Convertible Preferred Stock [Member]              
Conversion of stock into shares     67   232,151 8,990 67
Before Reverse Split [Member] | Series A Convertible Preferred Stock [Member]              
Conversion of stock into shares     1,000   3,445,266   1,000
NIS [Member]              
Monthly consultation fee   $ 40,000          
CardioSert Ltd [Member]              
Initial payment $ 250,000 $ 50,000          
Buy back amount per patent   $ 1.00          
CardioSert Ltd [Member] | Minimum [Member]              
Investments   $ 2,000,000          
Subsequent Event [Member]              
Buy back amount per patent   $ 1.00          
Conversion of stock into shares       101,063      
Subsequent Event [Member] | Series A Convertible Preferred Stock [Member]              
Conversion of stock into shares       1,500      
Subsequent Event [Member] | Before Reverse Split [Member]              
Conversion of stock into shares       1,500,000      
Subsequent Event [Member] | NIS [Member]              
Monthly consultation fee   $ 40,000,000          
Subsequent Event [Member] | Minimum [Member]              
Investments   $ 2,000,000          
Subsequent Event [Member] | CardioSert Ltd [Member]              
Patent description   closing of the acquisition expected in April 2018, CardioSert's issued U.S. patent and three patent applications pending worldwide will be added to Microbot's patent portfolio which will then have a patent portfolio of 25 issued/allowed patents and 15 patent applications pending worldwide.          
Initial payment   $ 50,000